Bogle Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Bogle Investment Management's BIIB Position: Q4 2020 in Review
Bogle Investment Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 11,575 shares — an estimated $3.28M sold.
Bogle Investment Management first reported a position in BIIB in Q2 2013 and held it in 16 quarters. The position peaked at $15.3M in Q1 2015. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.
- Bogle Investment Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
- Bogle Investment Management sold 11,575 Biogen shares in Q4 2020, an estimated $3.28M.
- Bogle Investment Management first reported a position in Biogen in Q2 2013 and held it in 16 quarters.
- Bogle Investment Management's Biogen position peaked at $15.3M in Q1 2015.
- 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.
Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.